| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 53.00M | 53.00M | 64.00M | 40.20M | 24.46M |
| Gross Profit | 36.10M | 36.10M | 47.00M | 24.30M | 16.31M |
| EBITDA | 36.10M | -64.10M | 49.40M | 33.80M | 52.93M |
| Net Income | -88.80M | -88.80M | 6.90M | 20.20M | 49.61M |
Balance Sheet | |||||
| Total Assets | 1.27B | 1.27B | 1.44B | 1.72B | 693.60M |
| Cash, Cash Equivalents and Short-Term Investments | 40.50M | 40.50M | 19.90M | 7.60M | 2.69M |
| Total Debt | 448.30M | 448.30M | 481.10M | 703.70M | 22.29M |
| Total Liabilities | 478.30M | 478.30M | 521.50M | 766.20M | 39.51M |
| Stockholders Equity | 788.00M | 788.00M | 912.60M | 951.20M | 654.09M |
Cash Flow | |||||
| Free Cash Flow | 23.30M | 18.30M | 6.40M | 888.90M | -473.92M |
| Operating Cash Flow | 23.30M | 18.30M | 6.40M | 11.10M | 19.96M |
| Investing Cash Flow | 78.90M | 83.90M | 41.50M | -961.90M | -522.47M |
| Financing Cash Flow | -81.60M | -81.60M | -35.60M | 944.10M | 501.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | AU$673.21M | 12.53 | 24.81% | 3.97% | 11.19% | 34.96% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
64 Neutral | AU$391.23M | 9.94 | 7.93% | 7.46% | -3.97% | 1057.09% | |
56 Neutral | AU$88.97M | -18.17 | -2.01% | 3.95% | -5.21% | -14350.00% | |
54 Neutral | AU$418.13M | -4.69 | -10.44% | 11.21% | -16.67% | -1419.67% | |
53 Neutral | AU$669.02M | -33.69 | -1.91% | 8.63% | -4.50% | 88.28% | |
49 Neutral | AU$61.64M | -1.73 | -23.55% | 15.14% | -68.24% | 42.03% |
HealthCo Healthcare & Wellness REIT announced updates on its capital management and tenant agreements, emphasizing efforts to maintain financial stability amid ongoing transitional challenges with Healthscope. Healthscope remains compliant with leasing obligations, while HCW proactively prepares to finalize lease agreements with alternative tenants for its hospital assets should the Healthscope sale process not meet terms. Additionally, HCW has implemented strategic asset sales generating $76.8 million in proceeds to ensure adequate liquidity and balance sheet strength. As a further measure to preserve liquidity, HCW will temporarily suspend quarterly distributions until the Healthscope situation is resolved, reflecting their operational focus and financial prudence.
The most recent analyst rating on (AU:HCW) stock is a Hold with a A$0.85 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT announced that all deferred rent from Healthscope for the May-October 2025 period has been fully paid, including the rent for November 2025. The company has entered into conditional agreements with alternative tenants for its 11 hospitals, ensuring continuity of service and maintaining jobs, should the current Healthscope sale process not yield satisfactory lease arrangements. Additionally, HCW reported a strong financial position with a pro-forma cash and undrawn debt of $137.5 million as of June 2025, and a gearing ratio below its target range. The portfolio occupancy stands at approximately 99%, with Healthscope contributing 59% of total income.
The most recent analyst rating on (AU:HCW) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.